Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Intensity Therapeutics management update

    Intensity Therapeutics Inc., Westport, Conn. Business: Cancer, Drug delivery Hired: Ian Walters as VP of clinical development and CMO

    Published on 9/8/2014
  • Ironwood management update

    Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass Business: Gastrointestinal Hired: Thomas Graney as SVP of finance and corporate strategy and CFO, formerly worldwide VP of finance and CFO of Johnson & …

    Published on 9/8/2014
  • Isogenica management update

    Isogenica Ltd., Little Chesterford, U.K. Business: Genomics, Proteomics, Supply/Service Transitioning: CSO Chris Ullman to CEO, effective Sept. 29; he will succeed Kevin Matthews, who will become CEO of Revolymer Ltd.

    Published on 9/8/2014
  • Kiadis Pharma management update

    Kiadis Pharma B.V., Amsterdam, the Netherlands Business: Cancer, Transplant, Gene/Cell therapy Hired: Jeroen Rovers as CMO, formerly CMO of Ceronco Biosciences B.V.

    Published on 9/8/2014
  • Mast Therapeutics management update

    Mast Therapeutics Inc. (NYSE-M:MSTX), San Diego, Calif. Business: Cardiovascular, Hematology, Cancer Hired: Edwin Parsley as interim CMO, formerly CMO of Aires Pharmaceuticals Inc., which Mast acquired; he succeeds …

    Published on 9/8/2014
  • Merck KGaA management update

    Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Pharmaceuticals, Other Hired: Drew Young as SVP of neurology and immunology at Merck's EMD Serono Inc. subsidiary, formerly marketing lead of the interferon franchise…

    Published on 9/8/2014
  • Moberg Pharma management update

    Moberg Pharma AB (SSE:MOB), Bromma, Sweden Business: Dermatology, Neurology Resigning: Steve Cagle as head of U.S. operations, effective January 2015 at the latest

    Published on 9/8/2014
  • Nabriva management update

    Nabriva Therapeutics AG, Vienna, Austria Business: Infectious Hired: Colin Broom as CEO, formerly CSO of ViroPharma Inc., which Shire plc acquired; he succeeds Ralf Schmid, who becomes COO and CFO

    Published on 9/8/2014
  • Oasmia management update

    Oasmia Pharmaceutical AB (SSE:OASM A), Uppsala, Sweden Business: Cancer, Drug delivery, Veterinary Hired: Anders Blom as EVP, effective Oct. 1, currently CEO of Nexttobe AB; he will succeed Hans Sundin, who is nominated…

    Published on 9/8/2014
  • PaxVax management update

    PaxVax Inc., Redwood City, Calif. Business: Infectious, Drug delivery Hired: Mark Meltz as EVP and chief legal officer, formerly associate general counsel at Biogen Idec Inc.

    Published on 9/8/2014
  • ProNAi management update

    ProNAi Therapeutics Inc., Kalamazoo, Mich. Business: Cancer Hired: Nick Glover as president and CEO, formerly president and CEO of YM BioSciences Inc., which Gilead Sciences Inc. acquired; he succeeds Mina Sooch

    Published on 9/8/2014
  • Propeller Health management update

    Propeller Health, Madison, Wis. Business: Bioinformatics Hired: Chris Hogg as COO, formerly CEO of mobile health company 100Plus, which he co-founded

    Published on 9/8/2014
  • Response Biomedical board of directors update

    Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Appointed: Lewis Shuster, a director, as chairman; he succeeds Peter Thompson, who remains a director

    Published on 9/8/2014
  • Roche board of directors update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Pharmaceuticals Resigned: Arthur Levinson, as a director

    Published on 9/8/2014
  • RuiYi management update

    RuiYi Inc., La Jolla, Calif. Business: Autoimmune, Cancer Hired: Mark Saad as CFO, formerly CFO of Cytori Therapeutics Inc.

    Published on 9/8/2014
  • TiGenix management update

    TiGenix N.V. (Euronext:TIG), Leuven, Belgium Business: Musculoskeletal, Gene/Cell therapy Hired: Marie Paule Richard as CMO, formerly CMO of AiCuris GmbH & Co. KG

    Published on 9/8/2014
  • Tokai management update

    Tokai Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Hired: Lee Kalowski as CFO, formerly VP of global biotechnology equity research at Credit Suisse

    Published on 9/8/2014
  • Voyager Therapeutics management update

    Voyager Therapeutics Inc., Cambridge, Mass. Business: Neurology Transitioned: Steven Paul, venture partner at Third Rock Ventures, to CEO from interim president of R&D, while remaining a director; he succeeds Mark Levin…

    Published on 9/8/2014
  • 4SC board of directors update

    4SC AG (Xetra:VSC), Planegg-Martinsried, Germany Business: Autoimmune, Cancer Resigning: Thomas Werner as chairman, effective Sept. 18

    Published on 9/1/2014
  • Acesion Pharma board of directors update

    Acesion Pharma ApS, Copenhagen, Denmark Business: Cardiovascular Appointed: Ingelise Saunders as chairman, currently a director at Leo Pharma A/S and chairman of MinervaX ApS

    Published on 9/1/2014
  • Acrux management update

    Acrux Ltd. (ASX:ACR), Melbourne, Australia Business: Drug delivery Hired: Michael Kotsanis, chief commercial officer of Synthon B.V., as CEO and managing director, effective Nov. 3; he will succeed Ross Dobinson, who …

    Published on 9/1/2014
  • Alchemia management update

    Alchemia Ltd. (ASX:ACL), Brisbane, Australia Business: Chemistry, Cancer, Hematology Hired: Jenni Pilcher as CFO, formerly secretary and CFO of Mesoblast Ltd.

    Published on 9/1/2014
  • Allergan management update

    Allergan Inc. (NYSE:AGN), Irvine, Calif. Business: Pharmaceuticals Transitioned: Jim Hindman to EVP of finance and business development and CFO from SVP of treasury, risk and investor relations; he succeeds Jeff Edwards

    Published on 9/1/2014
  • Basilea management update

    Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland Business: Infectious, Dermatology, Cancer Hired: David Veitch as chief commercial officer of Basileas Basilea Pharmaceutica International Ltd. subsidiary, formerly…

    Published on 9/1/2014
  • BeiGene management update

    BeiGene Co. Ltd., Beijing, China Business: Cancer Hired: Wendy Yan as SVP of regulatory affairs, formerly global regulatory strategist at Bayer AGs Bayer Healthcare AG subsidiary; and Jason Yang as SVP of clinical …

    Published on 9/1/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993